Poliana Espíndola Correia

Dr. Poliana Espíndola Correia


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
KZKelly P. Zucatti
Kelly P. Zucatti
PTPaula P. Teixeira
Paula P. Teixeira
LWLaura F. Wayerbacher
Laura F. Wayerbacher
GPGiovana F. Piccoli
Giovana F. Piccoli
PCPoliana Espíndola Correia
Poliana Espíndola Correia
Fernando GerchmanFernando Gerchman
Fernando Gerchman
BACKGROUND: Lifestyle interventions improve the metabolic control of individuals with hyperglycemia.PURPOSE: We aimed to determine the effect of lifestyle interventions on cardiovascular and all-cause mortality in this population.DATA SOURCES: Searches were made through MEDLINE, Cochrane CENTRAL, Embase, and Web of Science (no date/language restriction, until 15 May 2022).STUDY SELECTION: We included randomized clinical trials (RCTs) of subjects with prediabetes and type 2 diabetes, comparing intensive lifestyle interventions with usual care, with a minimum of 2 years of active intervention.DATA EXTRACTION: Data from the 11 RCTs selected were extracted in duplicate. A frequentist and arm-based meta-analysis was performed with random-effects models to estimate relative risk (RR) for mortality, and heterogeneity was assessed through I2 metrics. A generalized linear mixed model (GLMM) was used to confirm the findings.DATA SYNTHESIS: Lifestyle interventions were not superior to usual care in reducing cardiovascular (RR 0.99; 95% CI 0.79–1.23) or all-cause (RR 0.93; 95% CI 0.85–1.03) mortality. Subgroup, sensitivity, and meta-regression analyses showed no influence of type of intervention, mean follow-up, age, glycemic status, geographical location, risk of bias, or weight change. All of these results were confirmed with the GLMM. Most studies had a low risk of bias according to the RoB 2.0 tool and the certainty of evidence was moderate for both outcomes.LIMITATIONS: Most studies had a low risk of bias according to the RoB 2.0 tool, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach resulted in moderate certainty of evidence for both outcomes. Differences in lifestyle programs and in usual care between the studies should be considered in the interpretation of our results.CONCLUSIONS: Intensive lifestyle interventions implemented so far did not show superiority to usual care in reducing cardiovascular or all-cause mortality for subjects with prediabetes and type 2 diabetes.

21 June 2023 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
BSBernardo Frison Spiazzi
Bernardo Frison Spiazzi
ADAna Cláudia Duarte
Ana Cláudia Duarte
CZCarolina Pires Zingano
Carolina Pires Zingano
PTPaula Portal Teixeira
Paula Portal Teixeira
CACarmen Raya Amazarray
Carmen Raya Amazarray
VCVerônica Colpani
Verônica Colpani
Recent data from meta-analyses of randomized clinical trials (RCTs) suggest that dietary intake of coconut oil, rich in saturated fatty acids, does not result in cardiometabolic benefits, nor in improvements in anthropometric, lipid, glycemic, and subclinical inflammation parameters. Nevertheless, its consumption has surged in recent years all over the world, a phenomenon which can possibly be explained by an increasing belief among health professionals that this oil is as healthy as, or perhaps even healthier than, other oils, in [...] ABSTRACT Recent data from meta-analyses of randomized clinical trials (RCTs) suggest that dietary intake of coconut oil, rich in saturated fatty acids, does not result in cardiometabolic benefits, nor in improvements in anthropometric, lipid, glycemic, and subclinical inflammation parameters. Nevertheless, its consumption has surged in recent years all over the world, a phenomenon which can possibly be explained by an increasing belief among health professionals that this oil is as healthy as, or perhaps even healthier than, other oils, in

23 November 2022 in Obesity
Verified
Journal Article
Closed access
CACarina de Araujo
Carina de Araujo
RFRaquel C. Fitz
Raquel C. Fitz
GNGabriella Richter Natividade
Gabriella Richter Natividade
AOAmanda F. Osório
Amanda F. Osório
PMPaula N. Merello
Paula N. Merello
Fernando GerchmanFernando Gerchman
Fernando Gerchman

13 November 2023 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
GAGabrielle Gaspar Arejano
Gabrielle Gaspar Arejano
LHLaura Vargas Hoffmann
Laura Vargas Hoffmann
LWLinoska Ferreira Wyse
Linoska Ferreira Wyse
PCPoliana Espíndola Correia
Poliana Espíndola Correia
SPSimone Pieniz
Simone Pieniz
CBCarlos Castilho Barros
Carlos Castilho Barros
Objective: To study associations between polymorphisms in the angiotensin converting enzyme (ACE I/D), actinin 3 (ACTN3 R577X) and paraoxonase 1 (PON1 T(-107)C) genes and chronic diseases (diabetes and hypertension) in women. Materials and methods: Genomic DNA was extracted from saliva samples of 78 women between 18 and 59 years old used for genetic polymorphism screening. Biochemical data were collected from the medical records in Basic Health Units from Southern Brazil. Questionnaires about food consumption, physical activity level and socioeconomic [...] ABSTRACT Objective: To study associations between polymorphisms in the angiotensin converting enzyme (ACE I/D), actinin 3 (ACTN3 R577X) and paraoxonase 1 (PON1 T(-107)C) genes and chronic diseases (diabetes and hypertension) in women. Materials and methods: Genomic DNA was extracted from saliva samples of 78 women between 18 and 59 years old used for genetic polymorphism screening. Biochemical data were collected from the medical records in Basic Health Units from Southern Brazil. Questionnaires about food consumption, physical activity level and socioeconomic

26 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PCPoliana Espíndola Correia
Poliana Espíndola Correia
CGClarissa B. Gomes
Clarissa B. Gomes
VBVinicius A. Bandeira
Vinicius A. Bandeira
TMThais Marten
Thais Marten
GNGabriella Richter Natividade
Gabriella Richter Natividade
FGFernando Gerchman
Fernando Gerchman
The kallikrein–kinin system has been implicated in body weight and glucose homeostasis. Their major effectors act by binding to the kinin B2 and B1 receptors. It was assessed the role of the kinin B1 receptor in weight and glucose homeostasis in B1 receptor knockout mice (B1RKO) subjected to a cafeteria diet (CAF). Wild-type (WT) and B1RKO male mice (C57BL/6 background; 8 weeks old) were fed a standard diet (SD) or CAF for 14 weeks, ad libitum, and four groups were formed: WT-SD; B1RKO-SD; WT-CAF; B1RKO-CAF. Body weight and food intake were assessed weekly. It was performed glucose tolerance (GTT) and insulin tolerance tests (ITT), and HOMA-IR, HOMA-β and HOMA-β* 1/HOMA-IR were calculated. Islets from WT and B1RKO were isolated in order to measure the insulin secretion. Western blot was used to assess the hepatic AKT phosphorylation and qPCR to assess gene expression. CAF induced a higher body mass gain in B1RKO compared to WT mice. CAF diet increased epididymal fat depot mass, hepatic fat infiltration and hepatic AKT phosphorylation in both genotypes. However, B1RKO mice presented lower glycemic response during GTT when fed with CAF, and a lower glucose decrease in the ITT. This higher resistance was overcomed with higher insulin secretion when stimulated by high glucose, resulting in higher glucose uptake in the GTT when submitted to CAF, despite lower insulin sensitivity. Islets from B1RKO delivered 4 times more insulin in 3-month-old mice than islets from WT. The higher insulin disposition index and high insulin delivery of B1RKO can explain the decreased glucose excursion during GTT. In conclusion, CAF increased the β-cell function in B1RKO mice, compensated by the diet-induced insulin resistance and resulting in a healthier glycemic response despite the higher weight gain.

31 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
PCPoliana Espíndola Correia
Poliana Espíndola Correia
LBLauren Bisi
Lauren Bisi
MZMinghui Zhang
Minghui Zhang
YSYunxiang Sun
Yunxiang Sun
BMBárbara B. Martins
Bárbara B. Martins
Fernando GerchmanFernando Gerchman
Fernando Gerchman
Background: Brazil’s dietary patterns and significant socioeconomic and geographic diversity present unique challenges for the prevention of cardiometabolic diseases. Methods: In this cross-sectional study, we analyzed data from a nationwide representative survey to understand how dietary patterns related to cardiometabolic diseases. We classified the dietary pattern of participants as whole plant-based, processed plant-based, and animal-based. Then, they were categorized into high, intermediate, and low consumption. Logistic regression analysis was used to test the prevalence of obesity, hypertension, hypercholesterolemia, diabetes, stroke, and heart diseases according to the level of intake of each of the three dietary patterns. Results: Compared to the low intake of a whole plant-based dietary pattern, a high intake was associated with a lower prevalence of obesity (OR 0.64; 95% CI 0.54, 0.75) and hypercholesterolemia (OR 0.69, 95% CI 0.56, 0.85). A processed plant-based dietary pattern (including items such as soda and sweets) was inversely associated with the prevalence of obesity (OR 0.90; 95% CI 0.83, 0.97), hypertension (OR 0.82; 95% CI 0.76, 0.88), hypercholesterolemia (OR 0.81; 95% CI 0.74, 0.88), and diabetes (OR 0.53; 95% CI 0.48, 0.59). A high intake of animal-based dietary patterns was associated with a lower prevalence of heart diseases (OR: 0.60; 95% CI 0.40, 0.90). Conclusions: In this cross-sectional analysis, greater adherence to specific dietary patterns was associated with differences in the prevalence of cardiometabolic conditions. However, causality cannot be established, and longitudinal studies are warranted to confirm these findings.